Page last updated: 2024-11-04

imatinib and Inflammation

imatinib has been researched along with Inflammation in 4 studies

Inflammation: A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function.

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's1 (25.00)24.3611
2020's2 (50.00)2.80

Authors

AuthorsStudies
Chen, N1
Bürli, RW1
Neira, S1
Hungate, R1
Zhang, D1
Yu, V1
Nguyen, Y1
Tudor, Y1
Plant, M1
Flynn, S1
Meagher, KL1
Lee, MR1
Zhang, X1
Itano, A1
Schrag, M1
Xu, Y1
Ng, GY1
Hu, E1
Li, Y1
Lu, X1
Ren, X1
Ding, K1
Guan, B1
Jiang, C1
Marín-Rubio, JL1
Peltier-Heap, RE1
Dueñas, ME1
Heunis, T1
Dannoura, A1
Inns, J1
Scott, J1
Simpson, AJ1
Blair, HJ1
Heidenreich, O1
Allan, JM1
Watt, JE1
Martin, MP1
Saxty, B1
Trost, M1

Reviews

1 review available for imatinib and Inflammation

ArticleYear
Small molecule discoidin domain receptor kinase inhibitors and potential medical applications.
    Journal of medicinal chemistry, 2015, Apr-23, Volume: 58, Issue:8

    Topics: Amino Acid Sequence; Animals; Discoidin Domain Receptors; Drug Discovery; Humans; Inflammation; Liga

2015

Other Studies

3 other studies available for imatinib and Inflammation

ArticleYear
Discovery of a potent and selective c-Kit inhibitor for the treatment of inflammatory diseases.
    Bioorganic & medicinal chemistry letters, 2008, Jul-15, Volume: 18, Issue:14

    Topics: Animals; Chemistry, Pharmaceutical; Drug Design; Histamine Release; Inflammation; Inhibitory Concent

2008
Design and development of 1,3,5-triazine derivatives as protective agent against spinal cord injury in rat via inhibition of NF-ĸB.
    Bioorganic & medicinal chemistry letters, 2021, 06-01, Volume: 41

    Topics: Animals; Drug Design; Gene Expression Regulation; Inflammation; Lipopolysaccharides; Mice; Molecular

2021
A Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Assay Identifies Nilotinib as an Inhibitor of Inflammation in Acute Myeloid Leukemia.
    Journal of medicinal chemistry, 2022, 09-22, Volume: 65, Issue:18

    Topics: Cytokines; Drug Resistance, Neoplasm; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; Inflammat

2022